As biopharmaceutical processes have reached commercial scale and are key to providing lifesaving and life-changing therapies, the challenges of business continuity planning and supply chain risk mitigation are increasingly important. Key elements for a successful strategy and approach will be discussed with emphasis of the expectations on supply partners and relationships.



Objectives:

Review the challenges faced by the biopharmaceutical industry in supply chain risk mitigation.

Address how different companies define business continuity planning and approach supply chain risk mitigation.

Define what is important to consider in business continuity planning and the different strategies employed.